Latest filing published 03 Jun 2022 for ORTHOPEDIATRICS CORP.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Kevin Unger: trading record in brief
Kevin Unger (board member) discloses dealings in Orthopediatrics Corp to SEC (Form 4). Between 20 June 2018 and 1 June 2022, the trades on record add up to 7 filings.
Every open-market trade on record is a sale: 1 sale worth €28k. The rest of the record consists of 5 share grants and 1 option exercise.
On 3 June 2022 came the latest disclosure, a share grant in Orthopediatrics Corp. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Kevin Unger
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,691 shares0Common StockSEC:0001425450-22-000066:0
- 1,400 shares0Common StockSEC:0001425450-21-000101:0
2 of 2 declarations